Archetype Ventures funding is one of Tokyo's longest-running bets on early-stage B2B technology. Founded in 2006, this independent venture capital firm backs seed and early-stage startups across Japan and the United States, and has recorded 136 investments and 31 exits over nearly two decades. If you are building B2B software with global ambition from Asia, here is how the firm invests, what it has backed, and how founders reach it.
Thesis: what Archetype Ventures funding looks for
Archetype Ventures is a pure-play seed and early-stage investor in B2B technology. Its stated hunting grounds are SaaS, fintech, deeptech, AI/ML, healthcare, sustainability and marketing technology — in other words, enterprise software and applied technology rather than consumer apps. The firm concentrates on the earliest institutional rounds: Seed and Series A, when product-market fit is still being proven and a hands-on investor can shape the outcome. With a team of around ten professionals led by Managing Partner Shumpei Fukui, Archetype operates as a compact, founder-facing partnership rather than a mega-fund.
Cheque size & stages
Archetype invests at the Seed and Series A stages, primarily in Japan with selective bets in the United States. Its per-company cheque size is not publicly disclosed, and the firm does not publish a standard ticket range — founders should treat it as an early-stage lead or co-lead for institutional seed rounds. The firm's second institutional vehicle, Archetype Ventures Fund II (2023 vintage), continues the same seed/early-stage B2B tech mandate. PitchBook records 59 current portfolio companies, which suggests a concentrated, high-conviction book rather than spray-and-pray.
Notable portfolio
Archetype's portfolio spans enterprise automation, space, health and fintech. Verified names include Autoro (browser-based business process automation), Letara (hybrid propulsion for small spacecraft), Smolt (recycling-type aquaculture) and Bridgesmile (on-site installation services). Recent 2026 activity recorded by PitchBook includes Nocall.ai, Bulwark Dynamics, RoboTruck, Dioseve (biotech), Voxela (healthcare technology), LOOV, Sotas, Power Wave, TacSnap (fintech) and Revorn — a run of deals that underlines its current appetite for AI, healthtech and industrial technology. Its co-investor network has included Salesforce Ventures, NTT Docomo Ventures, SBI Investment and Google.
Programs & perks
Archetype runs no branded accelerator, and claims none. Its value-add is the classic early-stage VC package delivered hands-on: a small partnership that works closely with founders on go-to-market and follow-on fundraising, plus warm access to a co-investor network of Japanese corporates and global strategics. Founders should not expect cloud credits or structured perks programmes — the pitch here is partner time and network, not platform benefits.
How to apply for funding
There is no public application portal, so the route is a direct pitch through the firm's official website at archetype.vc or a warm introduction — ideally via a co-investor in its network such as NTT Docomo Ventures or SBI Investment, or through Japan's startup ecosystem channels. One practical warning: do not confuse this firm with the unrelated US crypto venture firm that shares the Archetype name — make sure your email lands in Tokyo, not New York.
Why it matters for founders
Archetype Ventures is a specialist, not a generalist: if you are an Indian or Asian founder building B2B SaaS, fintech or applied AI and want a Tokyo-based seed partner with a genuine US network, it belongs on your target list. Come with early traction and a clear enterprise wedge — and double-check you are pitching the Tokyo firm.